Gatekeepers.
We all know what that means if we are trying to reach a corporate executive, or trying to enter that wonderful nightclub.
Gatekeepers.
We all know what that means if we are trying to reach a corporate executive, or trying to enter that wonderful nightclub.
Sure, epigenetics (as a word) was coined some 400 years ago. But, it really wasn’t until the 1990s that we had a good handle on what it really is- and we’re still learning about what it really means.
Sometimes you just have to share bad information. Like a few weeks ago, when I reported that data indicated the nature of the microbiome population in a mom’s gut is associated with the development of autism spectrum disorders in their children. (My goal in publicizing this data was to alert parents-to-be of the issue- and to consider fecal transplantation if that issue could be applied to them.)
This is an “oh, sh..” moment for many a researcher. It seems that the premise of much of our research and drugs dealing with Alzheimer’s is completely wrong.
Ah, yes, another of my friends has been diagnosed with Alzheimer’s. And, according to the brain scans, this person has been suffering for a few years now- but only now are the memory loss issues coming to the fore.
OK. It’s bogeyman time.
Alzheimer’s! Yes. Even more than cancer- this word scares the bejesus out of us.
Sometimes, even your hoped for results astound you. Like, Dr. Hannah Iaccarino (MIT) found when she zapped a mouse with induced (but initial stages of) Alzheimer’s disease. The light caused brain wave induction (roughly 40 oscillations per second [Hz]). And, then she found that the toxic protein levels of amyloids halved.
What do we do when we just can’t lose weight?
No, don’t tell me we’re not trying hard enough. Some folks have fallen into the black hole of (no) weight loss- metabolic syndrome. I know that sounds like gobbledygook- and to some degree it is. Because it is not an illness per se, but a combination of risk factors that mean the subject is not losing weight, can succumb to heart disease, and/or diabetes.
Yesterday, we discussed the history of Parkinson’s disease and the initial attempts at treatments. Ones that didn’t seem to provide more than short term relief for the patients. Which is why research has continued- and new theories are being tested.
I’ve written about Parkinson’s Disease often. (Here, here, and here– for starters.) My grandfather, Sol Kuchlik (A’H) succumbed to the disorder. It, therefore, became one of those ailments (besides kidney and respiratory disorders) that attracted my attention over the years.
Continue reading Finally? A long-term treatment for Parkinson’s Disease?